黏膜表型浆细胞母细胞参与系统性红斑狼疮浆细胞增多
该研究分析活动性SLE患者外周血浆细胞母细胞的表型与迁移特性,发现其表达黏膜免疫标志物(IgA、CCR10、β7整合素),可向CCL28迁移并分泌多聚IgA,与口服疫苗诱导的浆细胞母细胞表型相似。黏膜表型浆细胞母细胞的出现与血清IL-2和PDGF-BB水平正相关,提示黏膜免疫系统过度活化与自身反应性浆细胞反应共同参与SLE浆细胞增多。
要点
- SLE活动期外周血浆细胞母细胞表达黏膜归巢标志物IgA、CCR10和β7整合素。
- 部分SLE浆细胞母细胞可向CCL28迁移并分泌多聚IgA,类似口服疫苗诱导的浆细胞母细胞。
- 黏膜表型浆细胞母细胞的出现与血清IL-2和PDGF-BB水平正相关。
核心结论
- SLE外周血浆细胞增多由黏膜稳态浆细胞母细胞反应和自身反应性浆细胞反应共同贡献。
研究设计与样本
- 比较活动性SLE、非活动/治疗SLE患者及健康对照的外周血浆细胞母细胞,采用流式细胞术、ELISPOT、Transwell迁移实验,并与疫苗诱导的浆细胞母细胞对比。
- 分析血清细胞因子水平(Luminex法)及肾活检组织学。
主要发现
- SLE循环浆细胞母细胞中IgA、CCR10和β7整合素表达率分别为48%、40%和38%,共表达模式各异。
- 部分SLE浆细胞母细胞向CCL28迁移并分泌多聚IgA,与口服疫苗而非肠外疫苗诱导的抗原特异性浆细胞母细胞表型相似。
- 可检测到IgG和IgA型自身反应性抗体分泌细胞,但仅黏膜表型浆细胞母细胞的出现与血清IL-2和PDGF-BB水平正相关。
临床怎么用
- SLE患者黏膜免疫系统过度活化,黏膜表型浆细胞母细胞可能成为评估疾病活动的免疫学标志。
- 针对黏膜免疫通路的干预可能为SLE治疗提供新思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the composition of known plasmacytosis in systemic lupus erythematosus (SLE) to obtain further insight into the nature of underlying mechanisms. METHODS: Plasmablasts from patients with active SLE, patients with inactive/treated SLE, and healthy controls were characterized by flow cytometry, enzyme-linked immunospot assay, and Transwell migration assays and compared to vaccination-induced plasmablasts. Serum cytokine levels were analyzed by Luminex assay, and histologic analysis of kidney biopsy specimens was performed. RESULTS: Circulating plasmablasts in SLE expressed markers of mucosal immune reactions. IgA, CCR10, and β7 integrin were expressed by 48%, 40%, and 38% of plasmablasts, respectively, with varying coexpression patterns. Consistent with mucosal homing, some SLE plasmablasts migrated toward the mucosal chemokine CCL28 and secreted polymeric IgA. SLE plasmablasts shared phenotypic characteristics with antigen-specific plasmablasts induced by oral, but not parenteral, vaccinations. Autoreactive antibody-secreting cells of the IgG and IgA isotypes were detectable, but only the emergence of phenotypically mucosal plasmablasts was positively associated with serum interleukin-2 and platelet-derived growth factor BB levels. CONCLUSION: Our data suggest that distinct plasmablast differentiation pathways jointly contribute to peripheral plasmacytosis in SLE, i.e., a cytokine-amplified mucosal "steady-state" plasmablast response, and an autoreactive plasmablast response, representing conventional autoimmunity. Our results indicate an overly activated mucosal immune system in patients with SLE, with both immunologic and clinical implications.
引用
- Mei HE, Hahne S, Redlin A, et al. Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017. PMID: 28622453. doi:10.1002/art.40181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。